PSA, an abbreviation for prostate-specific antigen, is a protein produced by the prostate, a small gland that sits below the bladder in males. PSA is present in small quantities in the blood of men with healthy prostates but can be elevated in the presence of prostate cancer or other prostate disorders, such as prostatitis or benign prostatic hyperplasia.
The level of PSA in the blood depends on several factors, such as age, race, family history, medication use, sexual activity, and the prostate size of the person. It can be produced by both cancerous and noncancerous tissue in the prostate.
PSA is a biomarker that can predict the risk of developing or worsening prostate cancer or the risk of developing or worsening other conditions that are associated with prostate cancer, such as urinary problems and sexual dysfunction. Nevertheless, its significance lies equally in physiological function in males, as it assists in the liquefaction of semen and allows sperm to swim smoothly and freely.[1-3]
PSA is both a diagnostic and prognostic marker of prostate health and state. Elevated PSA can be an early marker of future prostate dysfunction, even before changes in traditional prostate markers are observed.[4]
Each laboratory uses different machines and protocols, so the results might vary in terms of the reference ranges or used units of measurement. In Macromo blood tests, we use µg/l (micrograms per liter), but you may also find values in ng/ml (nanograms per millimeter) on the internet.
PSA levels are highly age-dependent, with an upper limit of around 2.5 µg/l (micrograms per liter) up to the age of 50. Higher levels may indicate an increased risk of prostate cancer or other related diseases. However, it is good to know that you can reduce or increase your PSA level by lifestyle changes
Your blood test can reveal various potential outcomes:
Scientists have discovered genetic changes in PSA levels and their connection to various factors, encompassing demographic characteristics, lifestyle choices, and genetic influences.
In particular, genetic contributors known as single nucleotide polymorphisms (SNPs) are linked to both PSA levels alone and in conjunction with prostate cancer. Notably, it has been revealed that the regulation of PSA levels involves genetic variations within the superfamily of organic anion-transporting polypeptides encoded by the SLCO2B1 and SLCO1B3 genes.
A study conducted among men in New Zealand has shed further light on the association between PSA levels and genetic polymorphisms in AKR1C3. These specific genetic variations have also been implicated in the development of prostate cancer.
This finding helps us understand the relationship between genetic factors and PSA levels and their potential implications for prostate health.[5]
If your results of PSA are outside the optimal range, there are several available options[6,7]:
The information and tests provided on our website are for educational purposes only and are not a substitute for professional medical advice. Always consult with your healthcare provider before making health decisions. Our tests do not diagnose or treat diseases. Individual results may vary and should be discussed with a healthcare provider.
Get the guidelines for a healthier and longer life. With Macromo tests, you'll learn your health risks and how to prevent them.
Continue to Shop
[1] Advising men without symptoms of prostate disease who ask about the PSA test. GOV.UK. Accessed July 8, 2023. https://www.gov.uk/government/publications/prostate-specific-antigen-testing-explanation-and-implementation/advising-well-men-about-the-psa-test-for-prostate-cancer-information-for-gps
[2] Prostate-Specific Antigen (PSA) Test - NCI. Published March 21, 2022. Accessed July 8, 2023. https://www.cancer.gov/types/prostate/psa-fact-sheet
[3] Co je PSA (prostatický specifický antigen) - Program časného záchytu karcinomu prostaty u populace mužů v dispenzární péči po onkologických onemocněních. Accessed July 8, 2023. https://nsc.uzis.cz/prostata/index.php?pg=co-je-psa
[4] Screening and Early Detection. Prostate Cancer Foundation. Accessed July 8, 2023. https://www.pcf.org/about-prostate-cancer/diagnosis-staging-prostate-cancer/screening-early-detection/
[5] Karunasinghe N, Minas TZ, Bao BY, et al. Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions. Sci Rep. 2022;12(1). doi:10.1038/s41598-021-04116-8
[6] Hackshaw-McGeagh L, Lane JA, Persad R, et al. Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial. Trials. 2016;17(1). doi:10.1186/s13063-016-1248-x
[7] Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®) - NCI. Published June 1, 2012. Accessed July 8, 2023. https://www.cancer.gov/about-cancer/treatment/cam/hp/prostate-supplements-pdq